Mannose Conjugated Starch Nanoparticles for Preferential Targeting of Liver Cancer.

Conclusion: In vivo, bio-distribution and plasma profile studies resulted in significantly higher concentration of 5- Fluorouracil liver suggesting that these carriers are efficient, viable, and targeted carrier of 5-FU treatment of liver cancer. PMID: 32885751 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32885751?dopt=Abstract

Source: Current Drug Delivery - September 2, 2020 Category: Drugs & Pharmacology Authors: Jain AK, Sahu H, Mishra K, Thareja S Tags: Curr Drug Deliv Source Type: research